Literature DB >> 16078832

Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.

William H Bisson1, Leonardo Scapozza, Gerrit Westera, Linjing Mu, P A Schubiger.   

Abstract

The homology models of the extracellular domains of the neuronal alpha4beta2 (pdb code: 1ole) and ganglionic alpha3beta4 (pdb code: 1olf) rat nicotinic acetylcholine receptor (nAChR) subtypes were refined and energetically minimized. In this work, a series of nAChR ligands (1-15) were docked into the modeled binding cavity of both receptors. High-affinity, toxic ligands such as epibatidine (1) and dechloroepibatidine (2) docked into cluster 1 with the charged tertiary amino group, forming a pi-cation interaction with Trp 147 on the (+) side of the alpha4 subunit and establishing a characteristic H-bond with the Lys 77 on the (-) side of the beta2 subunit. The nontoxic ligands such as 33bMet (3), (S)-A-85380 (4), and acetylcholine (6) docked into cluster 2 with the same pi-cation interaction but with the rest of the molecule occupying a different moiety of the binding pocket. Molecular docking into the alpha3beta4 subtype showed that both enantiomers of 1 (1a and 1b) are representative templates for ligands with affinity toward this ganglionic nAChR subtype. The ranking scores of the docked molecules confirm the existence of structure-dependent subtype selectivity and shed light on the design of specific and selective alpha4beta2 nAChR subtype ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078832     DOI: 10.1021/jm040881a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

2.  Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed.

Authors:  Nathan L Absalom; Gracia Quek; Trevor M Lewis; Taima Qudah; Ida von Arenstorff; Joseph I Ambrus; Kasper Harpsøe; Nasiara Karim; Thomas Balle; Malcolm D McLeod; Mary Chebib
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

3.  Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes alpha4beta2 and alpha7.

Authors:  William H Bisson; Gerrit Westera; P Augustus Schubiger; Leonardo Scapozza
Journal:  J Mol Model       Date:  2008-07-08       Impact factor: 1.810

Review 4.  Structural answers and persistent questions about how nicotinic receptors work.

Authors:  Gregg B Wells
Journal:  Front Biosci       Date:  2008-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.